Farooq, A., B. Zulfiqar, and K. Asghar. “Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma”. Journal of Cancer & Allied Specialties, Vol. 9, no. 1, Sept. 2022, doi:10.37029/jcas.v9i1.501.